Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from MEDIROM Healthcare Technologies ( (MRM) ) is now available.
On August 20, 2025, MEDIROM Healthcare Technologies announced its Key Performance Indicators for July 2025, highlighting a total of 76,544 customers served and a high sales per customer figure of JPY 7,389, which is significantly above the industry average. The company also reported a customer repeat ratio of 77.0% and an operation ratio of 44.8%. In its health tech business, MEDIROM has expanded its Lav® app user base to 10,842 and secured contracts with 101 corporate insurance associations, reflecting its growing influence in the health guidance market.
The most recent analyst rating on (MRM) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on MEDIROM Healthcare Technologies stock, see the MRM Stock Forecast page.
Spark’s Take on MRM Stock
According to Spark, TipRanks’ AI Analyst, MRM is a Neutral.
The overall stock score reflects strong technical momentum and reasonable valuation, offset by financial performance challenges. The high RSI suggests potential overbought conditions, while financial risks, particularly related to debt and cash flow, remain significant concerns.
To see Spark’s full report on MRM stock, click here.
More about MEDIROM Healthcare Technologies
MEDIROM Healthcare Technologies Inc. is a holistic healthcare company based in Japan, primarily focusing on salon operations and health tech services. The company operates a network of salons and offers a government-specific health guidance program through its Lav® app, targeting lifestyle-related diseases.
Average Trading Volume: 2,387,029
Technical Sentiment Signal: Buy
Current Market Cap: $14.93M
For an in-depth examination of MRM stock, go to TipRanks’ Overview page.